STOCK TITAN

Dorman Products (DORM) SEC Filings, Jul-Aug 2025

DORM NASDAQ
Rhea-AI Summary

The Form 144 notice records a proposed sale of 113 common shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $17,266.38 and an approximate sale date of 08/13/2025. The filing lists total shares outstanding as 30,534,243, so the proposed sale represents a very small fraction of the company’s outstanding stock. The securities to be sold were acquired by option grants dated 03/02/2022 and 03/02/2023 and payment is listed as cash.

The notice also discloses recent sales by Jeffrey Darby: 2,231 shares sold on 08/11/2025 for $317,597.63 and 9,191 shares sold on 08/12/2025 for $1,365,166.37. Key filing identifiers such as the issuer name and filer CIK are not present in the supplied text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
other
-
Rhea-AI Summary

Dorman Products, Inc. (DORM) Form 144 reports a proposed sale of 9,191 common shares with an aggregate market value of $1,365,166.37, against approximately 30,534,243 shares outstanding, with an approximate sale date of 08/12/2025 on NASDAQ.

The notice details how the securities were acquired: restricted stock vesting (1,005; 1,987; 575 shares on 02/20/2025, 02/28/2025, 03/04/2025) and option-related acquisitions reported on 08/12/2025 (1,018; 1,998; 1,477; 1,131 shares) with payment described as compensation or cash. The filing also discloses a recent sale on 08/11/2025 by Jeffrey Darby of 2,231 shares for $317,597.63. The filer attests to having no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.40%
Tags
other
-
Rhea-AI Summary

Dorman Products (DORM) filed a Form 144 proposing the sale of 1,213 shares of common stock through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $181,950 and an approximate sale date of 08/12/2025. The filing shows those 1,213 shares were acquired on 02/28/2025 through restricted stock vesting and paid as compensation on the same date.

The filing lists total shares outstanding of 30,534,243 and discloses a prior sale on 07/28/2025 of 820 shares that generated $100,211.63. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.77%
Tags
other
Rhea-AI Summary

Dorman Products, Inc. (DORM) filed a Form 144 reporting a proposed sale of 2,231 common shares with an aggregate market value of $317,597.63. The filing lists 30,534,243 shares outstanding and an approximate sale date of 08/11/2025 on NASDAQ.

The securities were acquired by the filer through stock option exercises (618 shares on 04/26/2018; 859 shares on 03/03/2023) and restricted stock vesting (754 shares on 03/01/2024), with payment described as cash for the exercises and compensation for the vesting. The filing notes Nothing to Report for sales during the past three months and includes the standard attestation that the filer does not know of undisclosed material adverse information. Submission is marked LIVE.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.77%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.87%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.87%
Tags
current report
Rhea-AI Summary

Form 4 – Dorman Products, Inc. (DORM)

SVP & CIO Donna M. Long reported two open-market sales on 28 Jul 2025:

  • 2 common shares at a weighted average price of $121.60
  • 818 common shares at a weighted average price of $122.2108

Aggregate shares sold: 820, for gross proceeds of roughly $100,000. Post-sale direct ownership declines to 19,073.8738 shares, a reduction of about 4 % of her prior position. No derivative securities were exercised or acquired, and no 10b5-1 trading plan is referenced.

The filing is routine and does not indicate any corporate events or financial performance issues. Given the modest size relative to both Long’s remaining stake and Dorman’s ~30 million-share float, the transaction is unlikely to exert meaningful pressure on the stock, but investors may track insider activity as a sentiment gauge.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
insider
-
Rhea-AI Summary

Dorman Products, Inc. (DORM) filed a Form 144 disclosing a planned discretionary sale by an affiliate/insider of 820 common shares—valued at approximately $100,040—through Fidelity Brokerage Services on or about 28 July 2025. The stake equals roughly 0.003 % of the company’s 30,511,174 shares outstanding and therefore is immaterial to float and daily trading volume.

The shares originated from restricted-stock vesting on 6 Mar 2022 and constitute non-cash compensation. The filer reports no other sales in the prior three months and certifies lack of undisclosed adverse information. While insider transactions can signal sentiment, the modest dollar amount and percentage suggest limited market impact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
other

FAQ

How many Dorman Products (DORM) SEC filings are available on StockTitan?

StockTitan tracks 88 SEC filings for Dorman Products (DORM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Dorman Products (DORM)?

The most recent SEC filing for Dorman Products (DORM) was filed on October 27, 2026.